C26 and CT26 colorectal cancer models exhibit divergent cachexia phenotypes, intramuscular inflammation, and protein turnover signaling
This study demonstrates that while both C26 and CT26 colorectal cancer cell lines induce skeletal muscle atrophy, the C26 model uniquely drives severe systemic cachexia characterized by body weight loss, impaired muscle function, and heightened inflammation, whereas CT26 exhibits a milder phenotype with less impact on overall physical function.